Milrinone vs. Dobutamine in Cardiogenic Shock: Which is Better?

Saving Lives Podcast: Critical Care w/eddyjoemd

Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

2y ago 8:57

M4A•에피소드 홈

Should we use milrinone or dobutamine in patients in cardiogenic shock? NEJM published data providing us with the answer.

In this episode, we explore the topic of cardiogenic shock and the use of two common medications, milrinone and dobutamine, in treating it. We examine the mechanisms of action, potential side effects, and clinical outcomes associated with each drug to determine which may be the better option for patients. Join us as we delve into this complex and important topic in critical care medicine.

Show Notes: https://eddyjoemd.com/milrinone-dobutamine/

TrueLearn Link: https://truelearn.referralrock.com/l/EDDYJOEMD25/
Discount code: EDDYJOEMD25

Citation: Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. N Engl J Med. 2021 Aug 5;385(6):516-525. doi: 10.1056/NEJMoa2026845. PMID: 34347952.

--- Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support

140 에피소드

#Fitness #Medicine #Eddy Joe, MD #Eddy Joe